96 related articles for article (PubMed ID: 3502389)
1. Measurement of immune complexes with the liquid phase C1q binding assay: ten years experience in a routine diagnostic laboratory.
Roberts-Thomson PJ; Neoh SH; Kennedy A; Smith MD; O'Donnell J; Bradley J
Asian Pac J Allergy Immunol; 1987 Dec; 5(2):149-54. PubMed ID: 3502389
[TBL] [Abstract][Full Text] [Related]
2. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.
Niven IP; Whaley K
Rheumatol Int; 1986; 6(5):205-8. PubMed ID: 3492025
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases.
Wener MH; Uwatoko S; Mannik M
Arthritis Rheum; 1989 May; 32(5):544-51. PubMed ID: 2785797
[TBL] [Abstract][Full Text] [Related]
5. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
Greisman SG; Redecha PB; Kimberly RP; Christian CL
J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
[TBL] [Abstract][Full Text] [Related]
6. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
Kilpatrick JM; Virella G
Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the fluid phase C1q binding assay. The effect of endogenous C1q on the precipitation and detection of an immune complex model.
Jacobs RJ; Mocharla R
J Immunol Methods; 1988 May; 109(2):265-75. PubMed ID: 3258897
[TBL] [Abstract][Full Text] [Related]
8. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
9. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
10. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
12. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
13. Detection of immune complexes and their relationship to rheumatoid factor in a variety of autoimmune disorders.
Pope RM; Yoshinoya S; McDuffy SJ
Clin Exp Immunol; 1981 Nov; 46(2):259-67. PubMed ID: 7337971
[TBL] [Abstract][Full Text] [Related]
14. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
[TBL] [Abstract][Full Text] [Related]
15. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Clq binding activity by IgM rheumatoid factor.
Zilberfarb JL; Andrews BS; Young AC; Davis JS
J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.
Scullion M; Balint G; Whaley K
J Clin Lab Immunol; 1979 Apr; 2(1):15-22. PubMed ID: 95801
[TBL] [Abstract][Full Text] [Related]
18. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
19. Association of C1q- and conglutinin-binding immune complexes with high consumption of alpha-2-macroglobulin in synovial fluids of patients with rheumatoid arthritis.
Borth W; Menzel JE
Int Arch Allergy Appl Immunol; 1984; 75(1):92-6. PubMed ID: 6204949
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]